BofA raised the firm’s price target on Delek US (DK) to $13 from $12 and keeps an Underperform rating on the shares. The firm, which refreshed its refiners estimates and notes it is below consensus for 2025 and 2026 EBITDA, points out that its price objectives for the “Majors” Chevron, ExxonMobil, and Occidental are “little changed,” but adds that it revised up its targets for refiners, as they no longer embed a worse case recessionary environment.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US upgraded to Outperform from Neutral at Mizuho
- Delek US Earnings Call: Balancing Growth and Challenges
- Delek US Holdings: Elevated Operating Expenses and Uncertain Initiatives Lead to Sell Rating
- Delek US Reports Q1 2025 Financial Results
- Delek US reports Q1 adjusted EPS ($2.32), consensus ($2.43)
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue